Cardiac safety implications of hNav1.5 blockade and a framework for preclinical evaluation
The human cardiac sodium channel (hNav1.5, encoded by the SCN5A gene) is critical for action potential generation and propagation in the heart. Drug-induced sodium channel inhibition decreases the rate of cardiomyocyte depolarization and consequently conduction velocity and can have serious implicat...
Saved in:
Main Authors: | Gul eErdemli (Author), Albert M Kim (Author), Haisong eJu (Author), Clayton eSpringer (Author), Robert C Penland (Author), Peter K Hoffmann (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phenotypic Screening in the 21st Century
by: Birgit T Priest, et al.
Published: (2014) -
Physiological and pathophysiological insights of Nav1.4 and Nav1.5 comparison
by: Gildas eLoussouarn, et al.
Published: (2016) -
Modeling the human Nav1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade
by: Ahmed M, et al.
Published: (2017) -
Acidosis differentially modulates inactivation in NaV1.2, NaV1.4, and NaV1.5 channels
by: Yury Y. Vilin, et al.
Published: (2012) -
Assessment of Outcome in Hypospadias Surgery - A Review
by: Alexander eSpringer
Published: (2014)